CSIMarket
 


Cumberland Pharmaceuticals Inc   (CPIX)
Other Ticker:  
 
 

CPIX's Revenue Growth by Quarter and Year

Cumberland Pharmaceuticals Inc 's Revenue results by quarter and year




CPIX Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 13.68 13.50 11.52
III Quarter September - 10.37 8.49 11.20
II Quarter June - 11.58 10.16 8.67
I Quarter March 8.33 11.90 8.59 9.64
FY   8.33 47.53 40.74 41.03



CPIX Revenue first quarter 2019 Y/Y Growth Comment
Cumberland Pharmaceuticals Inc reported fall in Revenue in the first quarter by -29.99% to $ 8.33 millions, from the same quarter in 2018.
The drop in the first quarter Cumberland Pharmaceuticals Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 6.09%.

Looking into first quarter results within Major Pharmaceutical Preparations industry 120 other companies have achieved higher Revenue growth. While Cumberland Pharmaceuticals Inc ' s Revenue drop of -29.99% ranks overall at the positon no. 2850 in the first quarter.




CPIX Revenue ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - 1.33 % 17.19 % 26.87 %
III Quarter September - 22.14 % -24.2 % 27.42 %
II Quarter June - 13.98 % 17.19 % 17 %
I Quarter March -29.99 % 38.53 % -10.89 % 24.55 %
FY   - 16.67 % -0.71 % 24.26 %

Financial Statements
Cumberland Pharmaceuticals Inc 's first quarter 2019 Revenue $ 8.33 millions CPIX's Income Statement
Cumberland Pharmaceuticals Inc 's first quarter 2018 Revenue $ 11.90 millions Quarterly CPIX's Income Statement
New: More CPIX's historic Revenue Growth >>


CPIX Revenue (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - 31.92 % 59.01 % 2.86 %
III Quarter September - -10.45 % -16.44 % 29.18 %
II Quarter June - -2.69 % 18.28 % -10.06 %
I Quarter March -39.1 % -11.85 % -25.43 % 6.17 %
FY (Year on Year)   - 16.67 % -0.71 % 24.26 %




Revenue first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #121
Healthcare Sector #397
Overall #2850

Revenue Y/Y Growth Statistics
High Average Low
58.5 % 6.09 % -47.9 %
(Dec 31 2014)   (Sep 30 2013)
Revenue first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #121
Healthcare Sector #397
Overall #2850
Revenue Y/Y Growth Statistics
High Average Low
58.5 % 6.09 % -47.9 %
(Dec 31 2014)   (Sep 30 2013)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Cumberland Pharmaceuticals Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
58.94 % 2.46 % -39.1 %
(Dec 31 2018)  


CPIX's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2019 Cumberland Pharmaceuticals Inc disclosed fall in Revenue sequentially by -39.1% to $ 8.33 millions, from $ 13.68 millions achived in the previous qaurter.

This is not important concern, as I. Quarter Revenue always gravitate to plunge in this quarter.

Within Major Pharmaceutical Preparations industry 125 other companies have achieved higher Revenue quarter on quarter growth. While Cumberland Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 2870.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #126
Healthcare Sector #394
Overall #2870
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #126
Healthcare Sector #394
Overall #2870
Revenue Q/Q Growth Statistics
High Average Low
58.94 % 2.46 % -39.1 %
(Dec 31 2018)  


CPIX's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2019 Cumberland Pharmaceuticals Inc realized fall in Revenue from the forth quarter by -39.1% to $ 8.33 millions, from $ 13.68 millions declared in the previous qaurter.

But that's not huge problem, as I. Quarter Revenue frequently gravitate to slow in this quarter Maya Thomas, Healthcare sector veteran situated in Philadelphia noted.

Within Major Pharmaceutical Preparations industry 125 other companies have achieved higher Revenue quarter on quarter growth. While Cumberland Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 2870.


Cumberland Pharmaceuticals Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Revenue 12 Months Ending $ 43.96 $ 47.53 $ 47.35 $ 45.47 $ 44.06
Y / Y Revenue Growth (TTM) -0.22 % 16.67 % 22.14 % 9.65 % 10.21 %
Year on Year Revenue Growth Overall Ranking # 1780 # 911 # 789 # 1504 # 1616
Seqeuential Revenue Change (TTM) -7.51 % 0.38 % 4.13 % 3.22 % 8.14 %
Seq. Revenue Growth (TTM) Overall Ranking # 2835 # 2334 # 964 # 1188 # 544




Cumulative Revenue growth Comment
For the 12 months ended Mar 31 2020 Cumberland Pharmaceuticals Inc reported a decrease in Revenue by -0.22% year on year, to $44 millions, compare to the 16.67% growth at Dec 31 2019.

In the Healthcare sector 260 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 911 to 1780.

Revenue TTM Q/Q Growth Statistics
High Average Low
10.83 %
2.3 %
-7.51 %
(Sep 30 2017)  

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 80
Healthcare Sector # 261
Overall # 1769

Revenue TTM Y/Y Growth Statistics
High Average Low
531.75 %
34.48 %
-15.22 %
(June 30. 2014)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 126
Sector # 402
S&P 500 # 2815
Cumulative Revenue growth Comment
For the 12 months ended Mar 31 2020 Cumberland Pharmaceuticals Inc reported a decrease in Revenue by -0.22% year on year, to $44 millions, compare to the 16.67% growth at Dec 31 2019.

In the Healthcare sector 260 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 911 to 1780.

Revenue TTM Q/Q Growth Statistics
High Average Low
10.83 %
2.3 %
-7.51 %
(Sep 30 2017)  


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 80
Healthcare Sector # 261
Overall # 1769

Revenue TTM Y/Y Growth Statistics
High Average Low
531.75 %
34.48 %
-15.22 %
(June 30. 2014)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 126
Sector # 402
S&P 500 # 2815




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CPIX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CPIX's Competitors
Revenue Growth for Cumberland Pharmaceuticals Inc 's Suppliers
Revenue Growth for CPIX's Customers

You may also want to know
CPIX's Annual Growth Rates CPIX's Profitability Ratios CPIX's Asset Turnover Ratio CPIX's Dividend Growth
CPIX's Roe CPIX's Valuation Ratios CPIX's Financial Strength Ratios CPIX's Dividend Payout Ratio
CPIX's Roa CPIX's Inventory Turnover Ratio CPIX's Growth Rates CPIX's Dividend Comparisons



Companies with similar Revenue decrease for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2020
Regenerx Biopharmaceuticals Inc -0.01 %$ -0.005 millions
Seaspine Holdings Corporation -0.11 %$ -0.108 millions
Bausch Health Companies Inc -0.20 %$ -0.198 millions
Abiomed Inc -0.20 %$ -0.204 millions
Mei Pharma Inc -0.40 %$ -0.400 millions
Tenet Healthcare Corp -0.55 %$ -0.550 millions
Mednax Inc -0.62 %$ -0.619 millions
Icu Medical Inc -0.70 %$ -0.703 millions
Neos Therapeutics Inc -0.96 %$ -0.964 millions
Hanger Inc -1.13 %$ -1.134 millions
Atricure Inc -1.37 %$ -1.373 millions
Integra Lifesciences Holdings Corp -1.49 %$ -1.492 millions
Spine Injury Solutions Inc -1.55 %$ -1.550 millions
Cryolife Inc -1.59 %$ -1.594 millions
United Therapeutics Corporation -1.74 %$ -1.737 millions
Conmed Corporation -2.00 %$ -2.000 millions
Invacare Corporation -2.23 %$ -2.229 millions
Lifeloc Technologies Inc -2.44 %$ -2.437 millions
Allied Healthcare Products Inc -2.63 %$ -2.631 millions
U S Physical Therapy Inc -3.02 %$ -3.023 millions
Icad Inc -3.19 %$ -3.189 millions
Integrated Biopharma Inc -3.24 %$ -3.244 millions
Livanova Plc -3.35 %$ -3.351 millions
Cardiovascular Systems Inc -3.37 %$ -3.374 millions
Sientra Inc -3.53 %$ -3.532 millions
Accuray Incorporated -3.56 %$ -3.558 millions
Quest Diagnostics Inc -3.65 %$ -3.649 millions
Harrow Health Inc -3.85 %$ -3.849 millions
Fonar Corp -3.89 %$ -3.891 millions
Nanostring Technologies Inc -3.91 %$ -3.911 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NVIV's Profile

Stock Price

NVIV's Financials

Business Description

Fundamentals

Charts & Quotes

NVIV's News

Suppliers

NVIV's Competitors

Customers & Markets

Economic Indicators

NVIV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071